Evans Daron → Viking Therapeutics, Inc. VKTX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 24/100

Passive Schedule 13G filer baseline
Held by 2 tracked 13F institutional managers
Moderate short days-to-cover (4.4 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 4.38

25,538,849 shares short · -1.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $14.44M

Point72 Asset MgmtSoros Fund Management

Other Filings by Evans Daron

Filed	Form	Issuer	Stake	Shares
2021-06-11	SC	NEPHROS INC NEPH	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →